NCT06855667View on ClinicalTrials.gov

Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Autoimmune Hepatitis
Interventions
BIOLOGICAL

Plasma Exchange

3 to 5 sessions alternate day

DRUG

Steroid

Steroid

DIETARY_SUPPLEMENT

Diet

Diet

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences (ILBS), New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT06855667 - Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis. | Biotech Hunter | Biotech Hunter